Abstract:BACKGROUNDThe p53 tumor suppressor protein is important in cell-cycle control, apoptosis, and DNA repair. Mutations in p53 have been associated with inherited cancer susceptibility. Because there is a difference in the risk of lung cancer among different ethnic groups, we examined associations between ethnicity and three polymorphisms in p53 (one exonic and two intronic) and haplotypes for the three loci and risk of lung cancer. We also examined the functionality of the p53 variants in apoptosis and DNA repair.METHODSIn a case-control study, we frequency matched (by age, sex, and ethnicity) 635 lung cancer case patients and 635 control subjects. p53 genotypes and haplotypes at the three polymorphic sites were determined by restriction fragment length polymorphism analysis of lymphocyte DNA. Odds ratios (ORs) and 95% confidence intervals (CIs) for the association between genotype or haplotype and lung cancer risk were determined by logistic regression analysis. Apoptosis and DNA repair capacity were measured in 22 lymphoblastoid cell lines to determine the functional effects of the polymorphisms. All statistical tests were two-sided.RESULTSGenotype and haplotype frequency distributions were strongly dependent on ethnicity; variant allele frequencies were highest in African-Americans (29.1%) and lowest in Mexican-Americans (12.2%). Each of the three polymorphisms was associated with an increased risk of lung cancer among all ethnic groups. Moreover, for all three polymorphisms, increased variant allele copy number was associated with increased risk of lung cancer. Similarly, the variant haplotypes were also associated with an increased risk for lung cancer. Lymphoblastoid cell lines with all wild-type alleles at the three loci had statistically significantly higher apoptotic indices (13.66%, 95% CI = 8.61% to 18.71%) and DNA repair capacity (27.63%, 95% CI = 21.72% to 33.53%) than cell lines with at least one variant allele at all three loci (3.50%, 95% CI = 1.08% to 5.91%; and 17.48%, 95% CI = 7.99% to 26.96%, respectively).CONCLUSIONSp53 polymorphisms may be associated with increased lung cancer risk and may affect p53 function.

p53 inactivating mutations in chinese breast carcinomas.

Association of p53 polymorphisms and its haplotypes with susceptibility of breast cancer]

[Analysis of the Mutations of BRCA1 in 9 Familiar Breast Cancer Patients].

Germline RECQL Gene Mutations in Chinese Patients with Breast Cancer

p53 Codon 72 polymorphism is associated with occurrence of cervical carcinoma in the Chinese population.

Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population

[Germline mutations of TP53 gene among Chinese families with high risk for breast cancer].

Frequency and Features of TP53 Mutation in 30 Chinese Patients with Sporadic Basal Cell Carcinoma.

[Human Papillomavirus, Human Cytomegalovirus and P53 Gene in Cervical Carcinoma].

Prevalence and Clinical Impact of TP53 Germline Mutations in Chinese Women with Breast Cancer

Prevalence and Characterization of BRCA1 and BRCA2 Germline Mutations in Chinese Women with Familial Breast Cancer

Association of TP53 Codon 72 Polymorphism with Cervical Cancer Risk in Chinese Women

Mutagen Sensitivity and P53 Expression in Colorectal Cancer in China.

[BRCA1/2 Gene Mutation in Chinese Familial Breast Cancer Patients: a Multi-Center Report of 115 Cases].

P53 Codon 72 Polymorphism (C/G) and the Risk of Human Papillomavirus-Associated Carcinomas in China

P53 GENE-MUTATIONS IN CHINESE HUMAN TESTICULAR SEMINOMA

The Prevalence of BRCA1 and BRCA2 Mutations in Eastern Chinese Women with Breast Cancer

Clinical Biology Value of P53 Overexpression in Chinese Breast Cancer by Meta Analysis

P53 Genotypes and Haplotypes Associated with Lung Cancer Susceptibility and Ethnicity.

BRCA1 and BRCA2 Gene Mutations of Familial Breast Cancer from Shanghai in China

Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.